Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-002344-16Phase 4Unknown
Phase 4, randomised, open-label trial of etanercept and methotrexate in rheumatoid arthritis (RA) (2 arms), sponsored by University of Leeds. Primary endpoint: Clinical remission at 24 weeks by baseline naive CD4+ T-cell frequency. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-002344-16.